Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 1 diabetes~* Treated with insulin for at least 12 months~* Either plan to become pregnant in the immediate future, willing to undertake pre pregnancy counselling, and has a screening HbA1c lesser than or equal to 12.0%, or~* Pregnant with normal singleton pregnancy, gestational age for at least 10 weeks at the time of randomisation, confirmed by ultrasound scan.~Exclusion Criteria:~* Previous birth of child with a major congenital malformation~* More than 2 previous multiple miscarriages or stillbirths~* Severe hyperemesis gravidarum, requiring hospitalisation, according to Investigator judgement~* Subjects being treated for infertility~* Proliferative retinopathy or maculopathy requiring acute treatment~* Drug or alcohol abuse~* Impaired renal, hepatic or cardiac function

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).